Yuhei Kirita

Yuhei Kirita

Auto-generated profile, based on publicly available information

Yuhei Kirita

Department of Nephrology, Kyoto Prefectural University of Medicine, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
HWHaojia Wu
Haojia Wu
YKYuhei Kirita
Yuhei Kirita
EDErinn L. Donnelly
Erinn L. Donnelly
BHBenjamin D. Humphreys
Benjamin D. Humphreys
Background: A challenge for single-cell genomic studies in kidney and other solid tissues is generating a high-quality single-cell suspension that contains rare or difficult-to-dissociate cell types and is free of both RNA degradation and artifactual transcriptional stress responses. Methods: We compared single-cell RNA sequencing (scRNA-seq) using the DropSeq platform with single-nucleus RNA sequencing (snRNA-seq) using sNuc-DropSeq, DroNc-seq, and 10X Chromium platforms on adult mouse kidney. We validated snRNA-seq on fibrotic kidney from mice 14 days after unilateral ureteral obstruction (UUO) surgery. Results: A total of 11,391 transcriptomes were generated in the comparison phase. We identified ten clusters in the scRNA-seq dataset, but glomerular cell types were absent, and one cluster consisted primarily of artifactual dissociation–induced stress response genes. By contrast, snRNA-seq from all three platforms captured a diversity of kidney cell types that were not represented in the scRNA-seq dataset, including glomerular podocytes, mesangial cells, and endothelial cells. No stress response genes were detected. Our snRNA-seq protocol yielded 20-fold more podocytes compared with published scRNA-seq datasets (2.4% versus 0.12%, respectively). Unexpectedly, single-cell and single-nucleus platforms had equivalent gene detection sensitivity. For validation, analysis of frozen day 14 UUO kidney revealed rare juxtaglomerular cells, novel activated proximal tubule and fibroblast cell states, and previously unidentified tubulointerstitial signaling pathways. Conclusions: snRNA-seq achieves comparable gene detection to scRNA-seq in adult kidney, and it also has substantial advantages, including reduced dissociation bias, compatibility with frozen samples, elimination of dissociation-induced transcriptional stress responses, and successful performance on inflamed fibrotic kidney.

22 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YKYuhei Kirita
Yuhei Kirita
HWHaojia Wu
Haojia Wu
KUKohei Uchimura
Kohei Uchimura
PWParker C. Wilson
Parker C. Wilson
BHBenjamin D. Humphreys
Benjamin D. Humphreys
Significance: Single nucleus RNA sequencing revealed gene expression changes during repair after acute kidney injury. We describe a small population of proximal tubule cells that fail to repair (FR-PTCs). Since this subpopulation expresses abundant proinflammatory and profibrotic genes, it may represent a new therapeutic target to improve repair and reduce fibrosis after AKI.

1 December 2018 in Cell Stem Cell
Verified
Journal Article
Closed access
HWHaojia Wu
Haojia Wu
KUKohei Uchimura
Kohei Uchimura
EDErinn L. Donnelly
Erinn L. Donnelly
YKYuhei Kirita
Yuhei Kirita
SMSamantha A. Morris
Samantha A. Morris
BHBenjamin D. Humphreys
Benjamin D. Humphreys

10 September 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PWParker C. Wilson
Parker C. Wilson
HWHaojia Wu
Haojia Wu
YKYuhei Kirita
Yuhei Kirita
KUKohei Uchimura
Kohei Uchimura
NLNicolas Ledru
Nicolas Ledru
BHBenjamin D. Humphreys
Benjamin D. Humphreys
Diabetic nephropathy is characterized by damage to both the glomerulus and tubulointerstitium, but relatively little is known about accompanying cell-specific changes in gene expression. We performed unbiased single-nucleus RNA sequencing (snRNA-seq) on cryopreserved human diabetic kidney samples to generate 23,980 single-nucleus transcriptomes from 3 control and 3 early diabetic nephropathy samples. All major cell types of the kidney were represented in the final dataset. Side-by-side comparison demonstrated cell-type–specific changes in gene expression that are important for ion transport, angiogenesis, and immune cell activation. In particular, we show that the diabetic thick ascending limb, late distal convoluted tubule, and principal cells all adopt a gene expression signature consistent with increased potassium secretion, including alterations in Na + /K + -ATPase, WNK1 , mineralocorticoid receptor, and NEDD4L expression, as well as decreased paracellular calcium and magnesium reabsorption. We also identify strong angiogenic signatures in glomerular cell types, proximal convoluted tubule, distal convoluted tubule, and principal cells. Taken together, these results suggest that increased potassium secretion and angiogenic signaling represent early kidney responses in human diabetic nephropathy.

6 July 2018 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
HWHaojia Wu
Haojia Wu
AMAndrew F. Malone
Andrew F. Malone
EDErinn L. Donnelly
Erinn L. Donnelly
YKYuhei Kirita
Yuhei Kirita
KUKohei Uchimura
Kohei Uchimura
BHBenjamin D. Humphreys
Benjamin D. Humphreys
Background Single-cell genomics techniques are revolutionizing our ability to characterize complex tissues. By contrast, the techniques used to analyze renal biopsy specimens have changed little over several decades. We tested the hypothesis that single-cell RNA-sequencing can comprehensively describe cell types and states in a human kidney biopsy specimen. Methods We generated 8746 single-cell transcriptomes from a healthy adult kidney and a single kidney transplant biopsy core by single-cell RNA-sequencing. Unsupervised clustering analysis of the biopsy specimen was performed to identify 16 distinct cell types, including all of the major immune cell types and most native kidney cell types, in this biopsy specimen, for which the histologic read was mixed rejection. Results Monocytes formed two subclusters representing a nonclassical CD16+ group and a classic CD16− group expressing dendritic cell maturation markers. The presence of both monocyte cell subtypes was validated by staining of independent transplant biopsy specimens. Comparison of healthy kidney epithelial transcriptomes with biopsy specimen counterparts identified novel segment-specific proinflammatory responses in rejection. Endothelial cells formed three distinct subclusters: resting cells and two activated endothelial cell groups. One activated endothelial cell group expressed Fc receptor pathway activation and Ig internalization genes, consistent with the pathologic diagnosis of antibody-mediated rejection. We mapped previously defined genes that associate with rejection outcomes to single cell types and generated a searchable online gene expression database. Conclusions We present the first step toward incorporation of single-cell transcriptomics into kidney biopsy specimen interpretation, describe a heterogeneous immune response in mixed rejection, and provide a searchable resource for the scientific community.

21 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YHYusuke Higuchi
Yusuke Higuchi
TSTatsuya Suzuki
Tatsuya Suzuki
TATakao Arimori
Takao Arimori
NINariko Ikemura
Nariko Ikemura
EMEmiko Mihara
Emiko Mihara
AHAtsushi Hoshino
Atsushi Hoshino
SARS-CoV-2 has mutated during the global pandemic leading to viral adaptation to medications and vaccinations. Here we describe an engineered human virus receptor, ACE2, by mutagenesis and screening for binding to the receptor binding domain (RBD). Three cycles of random mutagenesis and cell sorting achieved sub-nanomolar affinity to RBD. Our structural data show that the enhanced affinity comes from better hydrophobic packing and hydrogen-bonding geometry at the interface. Additional disulfide mutations caused the fixing of a closed ACE2 conformation to avoid off-target effects of protease activity, and also improved structural stability. Our engineered ACE2 neutralized SARS-CoV-2 at a 100-fold lower concentration than wild type; we also report that no escape mutants emerged in the co-incubation after 15 passages. Therapeutic administration of engineered ACE2 protected hamsters from SARS-CoV-2 infection, decreased lung virus titers and pathology. Our results provide evidence of a therapeutic potential of engineered ACE2.